According to DexCom's latest financial reports the company has a price-to-book ratio of 23.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 5.83 | -72.03% |
2022-12-31 | 20.8 | -18.19% |
2021-12-31 | 25.5 | 31.11% |
2020-12-31 | 19.4 | -14.38% |
2019-12-31 | 22.7 | 39.66% |
2018-12-31 | 16.3 | 36.69% |
2017-12-31 | 11.9 | -33.12% |
2016-12-31 | 17.8 | -41.22% |
2015-12-31 | 30.2 | -0.34% |
2014-12-31 | 30.4 | -0.57% |
2013-12-31 | 30.5 | 148.86% |
2012-12-31 | 12.3 | 103.94% |
2011-12-31 | 6.01 | -56.71% |
2010-12-31 | 13.9 | -168.96% |
2009-12-31 | -20.1 | 376.46% |
2008-12-31 | -4.23 | -111.9% |
2007-12-31 | 35.5 | 712.89% |
2006-12-31 | 4.37 | -42.54% |
2005-12-31 | 7.61 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.12 | -78.51% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 4.80 | -79.84% | ๐บ๐ธ USA |
Medtronic MDT | 2.04 | -91.45% | ๐ฎ๐ช Ireland |
Becton Dickinson BDX | 2.64 | -88.91% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 7.76 | -67.43% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | 7.27 | -69.50% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 0.5299 | -97.78% | ๐บ๐ธ USA |
West Pharmaceutical WST | 9.17 | -61.51% | ๐บ๐ธ USA |